Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-028583
Filing Date
2022-05-12
Accepted
2022-05-12 16:50:24
Documents
2
Period of Report
2022-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2175
2 POA DOCUMENT poa.txt EX-24 3361
  Complete submission text file 0001209191-22-028583.txt   6913
Mailing Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139 857-320-6400
Oncorus, Inc. (Issuer) CIK: 0001671818 (see all company filings)

EIN.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AILERON THERAPEUTICS, INC. 490 ARSENAL WAY WATERTOWN MA 02472
Business Address
Wanstall Rick (Reporting) CIK: 0001771222 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39575 | Film No.: 22918643